May 20, 2022 | Birmingham Research Park, Member News
Scientists from the University of Birmingham have shown an existing drug may reduce damage after spinal cord injury, by blocking the inflammatory response in the spinal cord. Their research, published in Clinical and Translational Medicine, demonstrates that...
Apr 25, 2022 | Birmingham Research Park, Member News
The University of Birmingham has created a new spinout, Healome TherapeuticsLtd, to commercially deploy a platform that delivers a ‘pro-healing’ microenvironment for the leading causes of preventable blindness. The company’s leading application will be in ocular...
Apr 21, 2022 | Birmingham Research Park, Member News
Birmingham researchers funded by Cancer Research UK and liquid biopsy company Nonacus have developed a new urine test for bladder cancer, which could reduce the need for invasive and time-consuming procedures to diagnose the disease. The test will use highly sensitive...
Mar 16, 2022 | Birmingham Research Park, Member News
Infectious disease diagnostics company Genetic Signatures has joined the BioHub Birmingham® as the launchpad for a planned further expansion into Europe, the Middle East and Africa. The BioHub is the first physical footprint within the UK and Europe for Genetic...
Mar 8, 2022 | Birmingham Research Park, Member News
The University of Birmingham has formed new spinout company, Michabo Health Science Ltd, to provide fast, reliable predictions of whether chemicals are potentially hazardous to human health or the environment. The company will use new methods developed by researchers...
Feb 1, 2022 | Birmingham Research Park, Member News
Matoke Holdings Ltd has joined the community of biomedical R&D companies located in the BioHub Birmingham® and announced the next phase of development for its Reactive Oxygen® technology, which is expected to deliver a major breakthrough in acute, surgical and...
